Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Trials ; 22(1): 215, 2021 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-33736678

RESUMEN

BACKGROUND: Hemiplegia is a common sequela after stroke, and acupuncture is one of the most common physical therapies used to treat hemiplegia during the recovery stage after ischaemic stroke. 'Hand and foot acupuncture with twelve needles' is an acupuncture treatment performed after stroke. The principal objective of this study is to assess the efficacy and safety of 'hand and foot acupuncture with twelve needles' for hemiplegia in the convalescent stage of ischaemic stroke. METHODS: This is the protocol for a randomised, controlled clinical trial with two groups: a 'hand and foot acupuncture with twelve needles' group and a routine acupuncture group. A total of 208 participants will be randomly assigned to two different groups in a 1:1 ratio and will undergo conventional rehabilitation. Limb function will be evaluated by the simplified Fugl-Meyer assessment scale, Barthel Index, modified Ashworth scale and National Institute of Health stroke scale. The participants will be evaluated at baseline (on the day of enrolment) and followed up at 2 weeks, 1 month, 2 months and 3 months after enrolment. DISCUSSION: The results of this study will provide evidence on the effectiveness of 'hand and foot acupuncture with twelve needles' in the treatment of limb dysfunction that can be used for future evaluations. TRIAL REGISTRATION: Chictr.org.cn ChiCTR1900021774 . Registered on 8 March 2019.


Asunto(s)
Terapia por Acupuntura , Isquemia Encefálica , Accidente Cerebrovascular Isquémico , Rehabilitación de Accidente Cerebrovascular , Accidente Cerebrovascular , Terapia por Acupuntura/efectos adversos , Isquemia Encefálica/diagnóstico , Isquemia Encefálica/terapia , Hemiplejía/diagnóstico , Hemiplejía/etiología , Hemiplejía/terapia , Humanos , Agujas , Qi , Ensayos Clínicos Controlados Aleatorios como Asunto , Accidente Cerebrovascular/diagnóstico , Accidente Cerebrovascular/terapia , Resultado del Tratamiento
2.
Zhongguo Zhong Yao Za Zhi ; 44(13): 2820-2826, 2019 Jul.
Artículo en Chino | MEDLINE | ID: mdl-31359696

RESUMEN

The aim of this study was to explore the effect of emodin on lipid accumulation and inflammation in hepatocytes. The cell morphology was observed by microscopy. LDH release was detected by the kit. Levels of intracellular lipid droplets were observed by oil red O staining. The contents of TC and TG in cells were detected by the kit. Western blot was used to determine protein expressions of FASN,SREBF2,APOB,IL-6 and p-NF-κB in hepatocytes. The results showed that the levels of L02 cell LDH were significantly increased after being treated with emodin,and the cells showed shrinkage,volume reduction,decrease in quantity with the increase of dose. Red lipid droplets were observed in L02 hepatocytes. Intracellular TC and TG contents of L02 cell increased in a concentrationdependent manner,with significant differences between medium and high-dose groups( P < 0. 05). Protein expressions of FASN,SREBF2,IL-6 and p-NF-κB were significantly higher than those of the control group,and the expression level of APOB was significantly lower than that of the control group( P<0. 05). In conclusion,emodin could induce lipid accumulation and inflammatory damage in hepatocytes in a dose-dependent manner,which in turn could damage liver cells. This process was related to the up-regulation of FASN,SREBF2,IL-6,p-NF-κB,as well as the down-regulation of the protein expression of APOB.


Asunto(s)
Emodina/farmacología , Hepatocitos/efectos de los fármacos , Metabolismo de los Lípidos , Apolipoproteína B-100/metabolismo , Células Cultivadas , Acido Graso Sintasa Tipo I/metabolismo , Hepatocitos/metabolismo , Humanos , Inflamación , Interleucina-6/metabolismo , Lípidos , FN-kappa B/metabolismo , Proteína 2 de Unión a Elementos Reguladores de Esteroles/metabolismo
3.
Int Urol Nephrol ; 47(3): 527-35, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25399356

RESUMEN

PURPOSE: We conducted this review to assess the relative efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in chronic kidney disease. METHODS: We systematically searched PubMed, EMBASE, the Cochrane Controlled Trial Register of Controlled Trials and Chinese Biological Medical Database for randomized controlled trials comparing lanthanum carbonate with calcium-based phosphate binders in adult patients with chronic kidney disease. Study quality was assessed using the criteria outlined in the Cochrane Handbook for Systematic Reviews of intervention. Meta-analysis was conducted by reviewer manager software, version 5.3. RESULTS: Eleven trials with 1,501 participants were included. Lanthanum carbonate appeared to be associated with a significant reduction in progression of vascular calcification and a beneficial effect on bone outcomes without aluminum-like toxicity. Lanthanum carbonate achieved similar proportions of phosphate-controlled patients (RR 0.63, 95% CI 0.27-1.44) with lower incidence of hypercalcemia (RR 0.13, 95% CI 0.05-0.35) in comparison with calcium-based phosphate binders. Lanthanum carbonate was associated with significantly lower serum calcium, similar serum Ca × P product and higher serum iPTH compared with calcium salts in patients with chronic kidney disease. CONCLUSION: Lanthanum carbonate could delay the progression of vascular calcification and benefit chronic kidney disease patients on bone outcomes. Lanthanum carbonate could achieve similar proportion of phosphate-controlled patients as calcium-based phosphate binders with lower incidence of hypercalcemia.


Asunto(s)
Quelantes/uso terapéutico , Lantano/uso terapéutico , Insuficiencia Renal Crónica/tratamiento farmacológico , Calcificación Vascular/prevención & control , Densidad Ósea/efectos de los fármacos , Calcio/sangre , Carbonato de Calcio/uso terapéutico , Quelantes/efectos adversos , Humanos , Hipercalcemia/sangre , Lantano/efectos adversos , Hormona Paratiroidea/sangre , Fósforo/sangre , Radiografía , Ensayos Clínicos Controlados Aleatorios como Asunto , Calcificación Vascular/diagnóstico por imagen
4.
Zhong Yao Cai ; 36(5): 767-71, 2013 May.
Artículo en Chino | MEDLINE | ID: mdl-24218970

RESUMEN

OBJECTIVE: To study the effect of the ethanol extract of stir-bake to yellowish Meliae Toosendan Fructus on nerve system and its mechanism. METHODS: The effect of the ethanol extract on sensory nerve was carried out through ache models induced by hot board method and radiant heat stimulation method in mice. The thermalgesia liminal value was investigated. The effect of the ethanol extract on the A-delta fiber and C fiber was measured by electrical stimulation procedure. Motor nerve conduction velocity (NCV) was measured by indirect detection method in vivo. The pathology changes of the motor nerve were observed by transmission electron microscope and the silver stain test. RESULTS: The ethanol extract of Meliae Toosendan Fructus could increase the thermalgesia liminal value of mice and reduce the conduction velocity of motor nerves. Meanwhile, pathology results showed the changes of the fiber of motor nerve, including demyelination and the number of Schwann cells dropping. CONCLUSION: The ethanol extract of stir-bake to yellowish Meliae Toosendan Fructus can reduce the pain sensitivity of mice and slow down NCV, which may be related to decreasing of the number of Schwann cells.


Asunto(s)
Meliaceae/química , Conducción Nerviosa/efectos de los fármacos , Umbral del Dolor/efectos de los fármacos , Dolor/fisiopatología , Extractos Vegetales/farmacología , Nervio Ciático/fisiopatología , Animales , Recuento de Células , Femenino , Frutas/química , Masculino , Ratones , Neuronas Motoras/fisiología , Fibras Nerviosas Amielínicas/fisiología , Conducción Nerviosa/fisiología , Dimensión del Dolor , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Ratas , Ratas Sprague-Dawley , Células de Schwann/fisiología , Nervio Ciático/efectos de los fármacos
5.
Fitoterapia ; 83(7): 1169-75, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22814126

RESUMEN

A new chlorinated flavonoid, 3, 6, 8-trichloro-5, 7, 3', 4'-tetrahydroxyflavone (1), a new biscoumaric acid derivative, 4-O-(2″, 3″-O-diacetyl-6″-O-p-coumaroyl-ß-D-glucopyranosyl)-p-coumaric acid (2), and 8, 3', 4'-trihydroxyflavone-7-O-ß-D-glucopyranoside (3) together with twenty-four known compounds (4-27) were isolated from the whole plant of Bidens bipinnata. All chemical structures were established on the basis of UV-, MS- and NMR (¹H, ¹³C, ¹H-¹H COSY, HMQC and HMBC) spectroscopic data. Some of the isolated compounds were tested for the inhibition of α-amylase. The result showed that isookanin (6) was a potent inhibitor of α-amylase (IC50=0.447 mg/ml).


Asunto(s)
Amilasas/antagonistas & inhibidores , Bidens/química , Chalconas/farmacología , Ácidos Cumáricos/farmacología , Inhibidores Enzimáticos/farmacología , Flavonas/farmacología , Fenoles/farmacología , Chalconas/química , Chalconas/aislamiento & purificación , Ácidos Cumáricos/química , Ácidos Cumáricos/aislamiento & purificación , Inhibidores Enzimáticos/aislamiento & purificación , Flavonas/química , Flavonas/aislamiento & purificación , Estructura Molecular , Fenoles/química , Fenoles/aislamiento & purificación , Extractos Vegetales/química , Extractos Vegetales/farmacología
6.
J Asian Nat Prod Res ; 12(4): 286-92, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20419539

RESUMEN

A new naphthoquinone dimer, arnebiabinone (1), a new phenolic compound, ethyl 9-(2',5'-dihydroxyphenyl) nonanoate (2), and a new natural product, octyl ferulate (3), were isolated from the EtOH extract of dried roots of Arnebia euchroma (Royle) Johnst. Their structures were elucidated on the basis of chemical reaction and spectral analysis.


Asunto(s)
Boraginaceae/química , Ácidos Cumáricos/aislamiento & purificación , Medicamentos Herbarios Chinos/aislamiento & purificación , Ácidos Grasos/aislamiento & purificación , Naftoquinonas/aislamiento & purificación , Ácidos Cumáricos/química , Medicamentos Herbarios Chinos/química , Ácidos Grasos/química , Estructura Molecular , Naftoquinonas/química , Resonancia Magnética Nuclear Biomolecular , Raíces de Plantas/química
7.
J Chromatogr B Analyt Technol Biomed Life Sci ; 852(1-2): 598-604, 2007 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-17383242

RESUMEN

Interaction of a commonly used combined prescription of Danggui Buxue Decoction (CPDBD) with protein was studied by microdialysis coupled with HPLC-DAD-MS. Nine compounds in CPDBD were unequivocally identified by comparing with their t(R), MS data and UV spectra with those of reference compounds, and simultaneously quantified. Microdialysis recoveries and binding degrees of 20 compounds in CPDBD with bovine serum albumin (BSA) were determined. Recoveries of microdialysis sampling ranged from 66.9 to 91.5% with RSD below 3.0%, and the binding degrees of those to BSA ranged from 6.3 to 59.8% (0.3mM BSA) and from 6.9 to 86.6% (0.6mM BSA). The results were determined at pH 7.4 and the influence of different pH value was investigated. Furthermore, the binding degrees of eight reference compounds were determined separately under the same conditions, indicating a significant effect of the interaction of compounds with each other on their binding degrees to BSA. By comparing their binding degrees with BSA with those of proven active compounds in CPDBD, i.e. chlorogenic acid (3), ferulic acid (6), ononin (12) and calycosin (16), other five compounds were found to possess potential activities, which were tentatively identified as calycosin-7-O-beta-D-glucoside-6-O-malonate (9), senkyunolide I or H (10), formononetin-7-O-beta-D-glucoside-6-O-malonate (17), and two unknown compounds.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Espectrometría de Masas/métodos , Extractos Vegetales/química , Medicamentos Herbarios Chinos , Concentración de Iones de Hidrógeno , Microdiálisis , Estándares de Referencia , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA